期刊文献+

哺乳动物细胞在生物技术药物研究与开发中的应用

Application on Mammalian Cells in Research and Development of Biopharmaceuticals
原文传递
导出
摘要 分析了20多年来欧美已上市的生物技术药物,指出哺乳动物细胞已成为生物技术药物研发主要采用的基因表达系统。对外源基因高表达工程细胞株、高效工程细胞培养工艺、工程细胞产物分离纯化技术及工程细胞制品的安全性评价等进行了综述分析,并论述了中国哺乳动物细胞工程化技术现状和在药物研发中的作用。 The licensed biopharmaeeutieals in U.S.A. and E.U. in last two decades have been reviewed in this paper.The authors pointed out that the gene expression system of mammalian cells has become major system in research and development of biopharmaeeuticals the progresses in construction of foreign gene high expressed engineered cell line was discussed, in process for large scale fermentation of mammalian cells and in safety evaluation of the products from mammalian cells. The authors also described the progress of biopharmaeeuticals produced with mammalian cell system in China.
作者 范秀媛 阮力
出处 《中国计划免疫》 2006年第5期420-425,共6页 Chinese Journal of Vaccines and Immunization
关键词 哺乳动物细胞 细胞工程技术 生物技术药物 Mammalian cell Engineering cell technology Biopharmaceutical
  • 相关文献

参考文献18

  • 1Walsh G.Biopharmaceutical benchmarks[J].Nature Biotechnology,2000,18:831-833.
  • 2胡显文,陈惠鹏,汤仲明,马清钧.美国、欧盟和中国生物技术药物的比较[J].中国生物工程杂志,2005,25(2):82-94. 被引量:33
  • 3Walsh G.Pharmaceutical biotechnology products approved within the European Union[J].Europ J Pharm Biopharm,2003,55:3-10.
  • 4Wurm FM.Production of recombinant protein therapeutics in cultivated mammalian cell cells[J].Nature biotechnol,2004,22(11):1393-1398.
  • 5Lloyd DR,Leelavatcharamas V,Emery AN,et al.The role of cell cycle in determining gene expression and productivity in CHO cells[J].Cytotechnology,1999,30:49-57.
  • 6Barnes L M,Bentley C M,Dickson AJ.Stability of protein production from recombinantant mammalian cells[J].Biotechnol Bioeng,2003,81(6):631-639.
  • 7Pak SCO,Hunt SMN,Bridges MW.Super-CHO A cell line capable of autocrinc growth under fully defined protein-free conditions[J].Cytotech,1996,22:139.
  • 8Schlenke P,Grabenhors E,Nimtz M,et al.Constrction and characterization of stably transfected BHK-21 cells with human-type sialytion characteristic[J].Cytotech,1999,30:17-25.
  • 9Moore A,Mercer J,Dutina G,et al.Effects of temperature shift on cell cycle,apoptosis and nucleotide pools in CHO cell batch culture[J].Cytotech,1997,23:47-54.
  • 10Yoon S K,Song J Y,Lee G M.Effect of low culture temperature on specific productivity,transcription level and heterogeneity of erythropoietin in Chinese hamster ovary cells[J].Biotechnol Bioeng,2003,82(3):289-298.

二级参考文献34

  • 1胡显文,陈惠鹏,汤仲明,马清钧.生物制药的现状和未来(一):历史与现实市场[J].中国生物工程杂志,2004,24(12):95-101. 被引量:37
  • 2胡显文,陈惠鹏,汤仲明,马清钧.生物制药的现状和未来(二):发展趋势与希望[J].中国生物工程杂志,2005,25(1):86-93. 被引量:32
  • 3陈胤忠,姜仁杰,沈进进,陈昌标,周聪玲,汤权,胡高兵,吴巨飞.基因重组乙型肝炎疫苗用于成人的免疫程序和接种剂量的研究[J].中国计划免疫,2005,11(2):100-105. 被引量:30
  • 4徐明波 何玮 马清钧 见:国家发展计划委员会高技术产业发展司 中.生物技术药品产业化的现状及前景[A].见:国家发展计划委员会高技术产业发展司,中国生物工程学会编.中国生物技术产业发展报告(2002)[C].北京:化学工业出版社,2003.35-43.
  • 5The Biopharmaceutical Industry: Overview, Prospects and Competitiveness Challenges. 2001(hppt :∥strategis. ic. gc. ca/epic/internet/inbio-pha. nsf/en/df00005e. html).
  • 6Bibby K, Davis J, Jones C. Biopharmaceuticals - Moving to Centre Stage. 2003 BioPeople North American Biotechnology Industry and Suppliers' Guide. 3-11, 2003. IMS marketing research report.(http:∥www. imshealth. com/vgn/images/portal/cit_40000873/43028586Bio_ Moving_ to-Centre_ Stage. pdf).
  • 7Walsh G. Biopharmaceutic benchmarks-2003. Nature Biotechnology, 2003, 21: 870 ~ 878.
  • 8Hiising B,Buhrlen B,Gaisser S.Human Tissue Engineered Products-Today's Markets and Future Prospects.April 28.2003.
  • 9Wurm F M. Production of recombinant protein therapeutics in cultivated mammalian cells. Nature Biotechnology, 2004, 22(11): 1393 ~ 1398.
  • 10Kretzmer G. Industrial processes with animal cells. Appl Microbiol Biotechnol, 2002, 59: 135~ 142.

共引文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部